3rd Quarter - Report
THE MCMANUS GROUP for GENENTECH
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to follow-on biologics. Support for H.R. 1548, "Pathway for Biosimilars Act." Opposition to H.R. 1427, "Promoting Innovation and Access to Life-Saving Medicine Act." Follow-on biologics provisions in S. ___, "Affordable Health Choices Act." Follow-on biologics provisions in H.R. 3200, "America's Affordable Health Choices Act of 2009."
Foreign entity interest: 100% ownership by Roche Holding Ltd., 4070 Bsel, Switzerland
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.